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The Nobel Prize in Chemistry 2004 
'Ubiquitous' Quality Control of Life 
C S Karigar and K R Siddalinga Murthy 
The Nobel Prize in Chemistry for 2004 is shared by Aaron 
Ciechanover, Avram Hershko and Irwin Rose, who made 
fundamental discoveries concerning how cells regulate the 
breakdown of cellular proteins with extreme specificity. 
The three biochemists discovered ubiquitin-mediated pro- 
teolysis, a process where an enzyme system tags unwanted 
proteins with many molecules of a small protein called 
ubiquitin and then sends then to the proteasome where they 
are broken down. 
Prote in  Degradat ion  i the  Cel l  
Eukaryotic ells, from yeast o humans, contain some 6000 to 
30000 protein-encoding genes and at least as many proteins. 
While much attention and research as been devoted to how 
proteins are synthesized, the reverse process, i.e. how proteins 
are degraded, has received little attention. Mammalian cells 
contain two distinct proteolytic pathways that are involved in 
different aspects of protein breakdown. Proteins that enter the 
cell from the extracellular milieu (such as receptor-mediated 
endocytosed proteins) are degraded in lysosomes under stress 
conditions. Nonlysosomal mechanisms are responsible for the 
highly selective turnover of intracellular proteins that occurs 
under both basal metabolic, as well as stress conditions. An 
important nonlysosomal proteolytic pathway is the energy 
requiring process involving the 'ubiquitin system' in which 
proteins are degraded by a 26S protease complex following 
conjugation by multiple molecules of 'ubiquitin'. The 'catalytic 
core' of the complex is a 20S protease complex also known as the 
proteasome. 
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The Core Particle (CP): The core particle is made of 2 
copies of each of 14 different proteins. 
These are assembled ingroups of 7 forming a ring. 
The 4 rings are stacked on each other (like 4 donuts). 
The Regulatory Particle (RP): There are two identical 
RPs, one at each end of the core particle. 
Each is made of 14 different proteins (none of them the 
same as those in the CP). 
Six of these are ATPases. 
Some of the subunits have sites that recognize the small 
protein ubiquitin. 
Ubiquitin: A small protein (76 amino acids). 
Conserved throughout all the kingdoms of life; that is, 
virtually identical in sequence whether in bacteria, yeast, or 
mammals. 
Used by all these creatures totarget proteins for destruction. 
STRUCTURE OF THE PROTEASOME 
Figure 1. Polyubiquitination 
and proteolysis. 
Ubiquitin 
Ubiquitin, a monomeric protein comprising 76 amino acids, is 
involved in the nonlysosomai protein degradation process. The 
structure of ubiquitin reveals an extended carboxyl terminus 
that is activated and linked to other proteins. Lysine residues on 
the molecule are important, including lysine 48, the major site 
for l inking additional ubiquitin molecules. Ubiquitin derives 
this name owing to its ubiquity and abundance in various cells 
and is one of the most highly conserved eukaryotic proteins 
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known (it is identical in such diverse organisms as humans, 
trout, and fruit fly) suggesting that it is uniquely suited for an 
essential cellular function. 
Figure 2. Role of protea- 
some in protein. 
Ubiqu i t inat ion  
There are two main steps involved in the protein ubiquitination: 
the covalent attachment ofan ubiquitin chain to the substrate 
(Figure 1), and specific recognition and degradation f the tagged 
protein by the 26S proteasome (Figure 2). 
Ubiquitination is a multiple step process. Ubiquitin is initially 
activated in the presence of ATP to a high-energy thiol ester 
intermediate by the ubiquitin-activating enzyme (El), which 
transfers ubiquitin via a thiol ester linkage to ubiquitin-conju- 
gating enzymes (E2s). E2s and/or ubiquitin-protein ligases (E3s), 
play an important role in the selection of proteins for conjuga- 
tion. They bind the first ubiquitin molecule to protein sub- 
strates via an isopeptide bond between the activated C-terminal 
glycine residue of ubiquitin and the ~-amino group of a lysine 
residue of the substrate. The resulting monoubiquitinated pro- 
tein is usually not targeted for degradation bythe proteasome. 
Alternatively, E2s and/or E3s catalyze the formation of 
polyubiquitinated conjugates. 
The ubiquitin-conjugating system in mammals consists of a 
single El, at least 20-30 E2s, and several dozens of E3s. 
Ubiquitinated proteins are dynamic entities with ubiquitin 
molecules being rapidly attached and removed. 
Ubiquitinated 
proteins are 
dynamic entities 
with ubiquitin 
molecules being 
rapidly attached 
and removed. 
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The first 
breakthrough came 
in 1978 when the 
reticulocyte xtract 
was passed over a 
DEAE-cellulose 
column to remove 
hemoglobin. 
Between 1981 and 
1983, Ciechanover 
and his colleagues 
worked out the 
multi-step 
ubiquitin-tagging 
hypothesis by 
isolating and 
characterizing 
three separate 
enzyme activities, 
El, E2 and E3. 
The Discovery of Ubiquitin-Mediated Proteolysis 
Aaron Ciechanover, Avram Hershko and Irwin Rose in a series 
of pioneering biochemical studies during the late 1970s and 
early 1980s discovered and characterized the ATP-dependent, 
ubiquitin-mediated protein degradation system using the reticu- 
locyte lysate system. 
The first breakthrough came in 1978 when the reticulocyte 
extract was passed over a DEAE-cellulose column to remove 
hemoglobin. The proteins eparated into two fractions, each one 
individually inactive, but recombination of the two fractions 
restored the ATP-dependent proteolysis. The first fraction, a 
heat-stable protein with a molecular weight around 9000 (called 
APF-1) was identified as ubiquitin by Wilkinson and his col- 
leagues. The following year Hershko, Ciechanover and Rose 
reported the separation of the second fraction by salt precipita- 
tion into an ATP-stabilized protein of around 450 kDa, contain- 
ing the proteasome, but nobody followed up the observation for 
almost a decade. The E I-E3 enzymes were later isolated from 
this fraction. All three fractions were required to degrade lz~I- 
labelled albumin as substrate. 
The second breakthrough came in 1980 and was described in 
two papers communicated to the journal, Proceedings of the 
National Academy of Sciences, USA. One was the unanticipated 
discovery of multiple ubiquitin conjugate to the same substrate 
molecule. Further, a deubiquitinating enzyme activity was also 
found in the lysate that could release the conjugated ubiquitin 
from substrate molecules. The paper demonstrated two novel 
enzymatic activities; an ubiquitin-protein amide synthetase and 
an amidase. A scheme (Scheme 1) was presented showing the 
proposed sequence of events in ATP-dependent protein degra- 
dation: 
These totally unexpected iscoveries completely changed the 
direction of the work. Instead of looking for an ATP-dependent 
protease, the group now sought to identify the enzyme system 
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Protein 
+ 
nAPF / ~ (APF).- Protein 
nATP 
nAPF-X + Amino acids 
1. APF-l-protein amide synthetase; 
2. Amidase; 
3. Peptidases; 
4. Amidase for APF-1-X where X is lysine or a small 
peptide. 
Scheme 1. 
that conjugated ubiquitin to the substrate. Between 1981 and 
1983, Ciechanover and his colleagues worked out the multi-step 
ubiquitin-tagging hypothesis by isolating and characterizing 
three separate nzyme activities, El, E2 and E3. During the 
purification of the ubiquitin-activating enzyme El, an elegant 
covalent affinity chromatography method was developed. This 
method was crucial for the subsequent purification of the E2 and 
E3 enzymes. When a reticulocyte lysate fraction containing the 
activating enzyme in the presence of ATP was applied to a 
Sepharose column containing covalently attached ubiquitin and 
then eluted with high-salt (E3), AMP plus pyrophosphate (El) 
and dithiothreitol (E2), the three fractions of E3, E1 and E2, 
respectively were recovered, which fully reconstituted ATP- 
dependent proteolysis when mixed with ubiquitin, ATP and 
unadsorbed fraction. The activating enzyme E1 was purified to 
homogeneity and is a homo-dimer, of 210 kDa. The E2 and E3 
fractions were further purified with gel filtration chromatogra- 
phy where the E2 activity eluted as a single peak with an 
apparent molecular weight of 35 kDa and the E3 activity as a 
peak with an apparent molecular weight of 300 kDa. Impor- 
tantly, the gel filtration profiles of the ubiquitin conjugation 
activities of El, E2 and E3 were identical to their protein 
The gel filtration 
profiles of the 
ubiquitin conjugation 
activities of El, E2 
and E3 were 
identical to their 
protein degradation 
activities. 
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degradation activities. Therefore, the three enzymes of the 
ubiquitin-protein ligase system were identical with the three 
factors participating in protein degradation. 
They hypothesized that E1 transfers ubiquitin to E2 and E2 
participates in the transfer of ubiquitin finally to the substrate. 
No ubiquitin transfer from El-ubiquitin to E3 was detected. 
Instead, E3 catalysed the transfer of labeled ubiquitin from E2 to 
the protein substrate, forming amide bonds. The full conjuga- 
tion pathway involves binding of activated ubiquitin via its 
COOH terminal glycine to the thiol site of El followed by its 
transfer to another sulfhydryl site on E2. Ubiquitin is then 
further transferred from E2-bound thiol esters to stable protein 
conjugates in the presence of E3. The E3 catalysed reaction is 
iterated on the original substrate, resulting in polyubiquitination. 
All the above studies were made in a cell-free system. 
P,,,r~e i n Protein- 
E3 : Ub,~ 
To study the physiological functions of ubiquitin-mediated 
proteolysis, Hershko et al devised an immunochemical method 
for isolating ubiquitin-protein conjugates from intact cells. Cells 
were first pulse-labeled with tryptophan, an amino acid that is 
absent in ubiquitin. Using an antibody against ubiquitin, they 
could then specifically measure proteolysis of the protein sub- 
strate of ubiquitin conjugates. The results showed a marked 
increase in labeled ubiquitin-protein conjugates during the for- 
mation of abnormal proteins in reticulocytes induced by adding 
amino acid analogues. The ubiquitin-protein conjugates were 
degraded more rapidly than general cell proteins. The phenom- 
enon was not restricted to reticulocytes, but was also observed in 
Ehrlich ascites cells. These data were consistent with the inter- 
pretation that the degradation of abnormal intracellular pro- 
teins is carried out by ubiquitin-mediated proteolysis. However, 
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the results "do not exclude the participation of the ubiquitin 
pathway in some other types of protein breakdown". There is 
now experimental evidence that up to 30% of the newly synthe- 
sized polypeptides in a cell are selected for rapid degradation i  
the proteasome because they do not pass the quality control 
system of the cell. 
Role of Proteasome in Protein Degradation 
The second major step in the ubiquitin-proteasome pathways i
the degradation of polyubiquitinated proteins by the 26S 
proteasome, which is formed by the binding of two 19S regula- 
tory complexes with the 20S proteasome. Proteasomes are found 
both in the nucleus and in the cytoplasm, and the active sites of 
the proteasome are protected from the cellular environment in 
the interior of the barrel-shaped 20S structure. The 19S complex 
is an activator that stimulates both peptidase and proteolytic 
activities of the 20S proteasome. This complex contains at least 
18 different subunits and can be topologically defined by two 
subcomplexes called the base and the lid. The base contains ix 
ATPases, and two non-ATPase subunits in yeast. The ATPases 
provide energy for the assembly of the 26S proteasome and the 
breakdown of ubiquitinated proteins into peptides, for the gat- 
ing of the proteasome channel, and presumably the unfolding of 
protein substrates, and their injection into the catalytic hamber 
of the proteasome. The binding of the 20S proteasome to the 
base alone supports ATP-dependent peptide hydrolysis. In con- 
trast, both the base and the lid are required for ubiquitin- 
dependent proteolysis. The lid contains at least eight non- 
ATPase subunits. Subunit S5a binds tightly to the polyubiquitin 
degradation signal. Another subunit or several additional sub- 
units may also act as a polyubiquitin-conjugate receptor. The 
19S regulatory subcomplexes of the proteasome unfold the pro- 
tein substrates and assist in their translocation through anarrow 
gate into the 20S core particle where degradation takes place. 
The protein substrates are degraded progressively until peptides 
of 7-9 amino acid residues remain. The 19S complex also con- 
tains an isopeptidase that removes ubiquitin from the substrate 
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Terms and Meanings 
Proteasome: Molecular machine that degrades proteins that are synthesized within the cell. 
Ubiquitination: The process of covalent attachment of an ubiquitin chain to the protein for degradation. 
Reticulocyte lysate: This extract or lysate contains the components required for translation and degrada- 
tion of proteins for in vitro studies. 
DEAE-cellulose column: Ion exchange chromatography matrix for separation of charged molecules. 
APF- I :  Active Protein Fraction - I. 
Salt precipitation: A laboratory method for precipitation of proteins. 
Deubiquitination: Release of the conjugated ubiquitin from protein molecules by deubiquitinating 
enzyme found in the lysate. 
Polyu biq uitination: Poly-ubiquitination fsubstrate proteins is the signal for proteolysis by the proteasome. 
Monoubiquitinatinn: Signal for endocytosis of a plasma membrane-embedded receptor proteins. 
C-terminal glycine: Attachment site for ubiquitin. 
Pulse-label: Addition of radioactive [35 S]methionine to the reticulate lysate for translation analysis. 
Ehrlich ascites cells: Epithelial mouse carcinoma cells of use in comparative t sting of anti tumour agents 
for in vivo and in vitro studies. 
ATPases: Adenosine triphosphatases are enzymes essential for deriving cellular energy. They hydrolyse 
ATP to release its chemical energy. 
Multiple myeloma: A cancer of the plasma cell. 
Transcription factors: A protein eeded to initiate the transcription ofa gene. Some transcription factors 
bind to specific sequences of DNA (promoters and enhancers); others bind to each other; many bind both 
to DNA as well as to other transcription factors. 
Cell cycle: An eukaryotic ell divides by doubling of its genome and halving of the genome into daughter 
cells. It consists of: G j= growth and preparation ofthe chromosomes for replication, S = synthesis of DNA, 
G 2 = preparation for mitosis, and M = mitosis. 
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protein. Surprisingly, the base of the 19S complex has also 
chaperone-like activity and is able to refold a denatured protein 
in vitro, a function opposite to its presumed role in proteolysis. 
Poly-ubiquitination fsubstrate proteins is the signal eading to 
proteolysis in the proteasome. However, monoubiquitination f 
a plasma membrane-embedded receptor was later found to signal 
its endocytosis, indicating that ubiquitination of proteins also 
has important targeting functions in endocytosisand secretion. 
A non-proteolytic function ofubiquitir~was discovered by Finley 
and coworkers. They identified three yeast ubiquitin genes that 
bring about fusions of ubiquitin to ribosomal proteins, which is 
required for efficient biogenesis of ribosomes. There are now 
many examples of a non-proteolytic function of ubiquitination, 
or modification by the small ubiquitin-related modifier (SUMO). 
Ub iqu i t in  System, a Target for Drug Development 
Since the late 1980s, a rapidly growing number of physiological 
substrates of the ubiquitin-mediated proteolysis ystem have 
been identified. They include the cell cycle, DNA repair and 
transcription, protein quality control and the immune response. 
Defects in this proteolysis have a causal role in many human 
diseases, including a variety of cancers. The ubiquitin system 
has become an interesting target for the development of drugs 
against various diseases. Such drugs may be directed against 
components of the ubiquitin-mediated proteolysis ystem to 
prevent degradation of specific proteins or the reverse; drugs 
may trigger the system to destroy unwanted proteins. One drug 
already in clinical trials is the proteasome inhibitor Velcade 
(PS341), that is approved for treatment of multiple myeloma. 
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